Homoharringtonine
| Homoharringtonine | |
|---|---|
| Term | Homoharringtonine |
| Short definition | Homoharringtonine (hoh-moh-HAYR-ing-tuh-neen) A drug used to treat adults with certain types of chronic myeloid leukemia who are not treated with tyrosine kinase inhibitors (a type of cancer drug). or who have not improved after treatment with at least two tyrosine kinase inhibitors. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Homoharringtonine - (pronounced) (hoh-moh-HAYR-ing-tuh-neen) A drug used to treat adults with certain types of chronic myeloid leukemia who are not treated with tyrosine kinase inhibitors (a type of cancer drug). or who have not improved after treatment with at least two tyrosine kinase inhibitors. It is also being studied in the treatment of other types of cancer. Homoharringtonine blocks certain proteins involved in cell growth and can kill cancer cells. It is a type of plant alkaloid and a type of protein synthesis inhibitor. Also called omacetaxine mepesuccinate and synribo
External links
- Medical encyclopedia article on Homoharringtonine
- Wikipedia's article - Homoharringtonine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski